Tapewire

Nasdaq · USD

COLL

COLLEGIUM PHARMACEUTICAL, INC

Export transactions ↓
Tapewire entity
5169
SEC CIK
0001267565
Parsed reports
359

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202503
Jan 202600
Feb 202600
Mar 202604
Apr 202600
May 202604
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 25, 2019 Filed Jan 29, 2019 16:37 UTC
Kuhlmann Shirley R.EVP and General Counsel
GrantCommon Stock 25,600 $0.00 $0.00
Disclosure

SEC source: 0001192482-19-000055 · edgar.xml · nonDerivative · entry 1

Kuhlmann Shirley R. · CIK 0001734919 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,600

F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2020, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
January 25, 2019 Filed Jan 29, 2019 16:42 UTC
Fleming Alison BChief Technology Officer
GrantStock Option (Right to Purchase) · Derivative 25,600 $0.00 Strike: $15.90 $0.00
Disclosure

SEC source: 0001192482-19-000059 · edgar.xml · derivative · entry 2

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,600

Underlying: Common Stock · 25,600 shares

Expires 2029-01-25

F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
January 25, 2019 Filed Jan 29, 2019 16:42 UTC
Fleming Alison BChief Technology Officer
GrantCommon Stock 25,600 $0.00 $0.00
Disclosure

SEC source: 0001192482-19-000059 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,968

F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2020, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
January 25, 2019 Filed Jan 29, 2019 21:33 UTC
Ciaffoni JosephDirector · President and CEO
GrantStock Option (Right to Purchase) · Derivative 90,000 $0.00 Strike: $15.90 $0.00
Disclosure

SEC source: 0001192482-19-000053 · edgar.xml · derivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2029-01-25

F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
January 25, 2019 Filed Jan 29, 2019 21:33 UTC
Ciaffoni JosephDirector · President and CEO
GrantCommon Stock 90,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-19-000053 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,658

F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2020, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
January 25, 2019 Filed Jan 29, 2019 21:46 UTC
Dreyer ScottEVP & Chief Commercial Officer
GrantStock Option (Right to Purchase) · Derivative 25,600 $0.00 Strike: $15.90 $0.00
Disclosure

SEC source: 0001192482-19-000061 · edgar.xml · derivative · entry 2

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,600

Underlying: Common Stock · 25,600 shares

Expires 2029-01-25

F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
January 25, 2019 Filed Jan 29, 2019 21:46 UTC
Dreyer ScottEVP & Chief Commercial Officer
GrantCommon Stock 25,600 $0.00 $0.00
Disclosure

SEC source: 0001192482-19-000061 · edgar.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,786

F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2020, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
January 25, 2019 Filed Jan 29, 2019 21:39 UTC
Brannelly PaulExecutive Vice President & CFO
GrantStock Option (Right to Purchase) · Derivative 32,000 $0.00 Strike: $15.90 $0.00
Disclosure

SEC source: 0001192482-19-000057 · edgar.xml · derivative · entry 2

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,000

Underlying: Common Stock · 32,000 shares

Expires 2029-01-25

F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
January 25, 2019 Filed Jan 29, 2019 21:39 UTC
Brannelly PaulExecutive Vice President & CFO
GrantCommon Stock 32,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-19-000057 · edgar.xml · nonDerivative · entry 1

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,981

F1 · security: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2020, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
January 18, 2019 Filed Jan 23, 2019 16:17 UTC
Fleming Alison BChief Technology Officer
Tax withholdingCommon Stock 214 $15.76 $3,372.64
Disclosure

SEC source: 0001192482-19-000041 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,368

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
January 18, 2019 Filed Jan 23, 2019 21:14 UTC Tax withholdingCommon Stock 787 $15.76 $12,403.12
Disclosure

SEC source: 0001192482-19-000039 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 285,213

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
January 18, 2019 Filed Jan 23, 2019 21:13 UTC
Brannelly PaulExecutive Vice President & CFO
Tax withholdingCommon Stock 214 $15.76 $3,372.64
Disclosure

SEC source: 0001192482-19-000037 · edgar.xml · nonDerivative · entry 1

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,981

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
January 15, 2019 Filed Jan 17, 2019 21:16 UTC SaleCommon Stock 25,000 $15.56 $389,000.00
Disclosure

SEC source: 0001192482-19-000030 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 286,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2018.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.31 to $16.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).

Read SEC document
December 17, 2018 Filed Dec 18, 2018 22:09 UTC SaleCommon Stock 3,313 $18.57 $61,522.41
Disclosure

SEC source: 0001192482-18-000506 · edgar.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2018.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.50 to $18.65, inclusive.

Read SEC document
December 17, 2018 Filed Dec 18, 2018 22:09 UTC SaleCommon Stock 21,687 $18.12 $392,968.44
Disclosure

SEC source: 0001192482-18-000506 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 314,313

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2018.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.50 to $18.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
November 30, 2018 Filed Dec 3, 2018 22:05 UTC
Ciaffoni JosephDirector · President and CEO
Tax withholdingCommon Stock 4,683 $19.19 $89,866.77
Disclosure

SEC source: 0001192482-18-000484 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,658

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
November 15, 2018 Filed Nov 16, 2018 21:19 UTC SaleCommon Stock 3,600 $17.05 $61,380.00
Disclosure

SEC source: 0001192482-18-000479 · edgar.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 336,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2018.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.00 to $17.06, inclusive.

Read SEC document
November 15, 2018 Filed Nov 16, 2018 21:19 UTC SaleCommon Stock 21,400 $16.53 $353,742.00
Disclosure

SEC source: 0001192482-18-000479 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,600

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2018.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.00 to $16.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).

Read SEC document
November 14, 2018 Filed Nov 16, 2018 21:16 UTC OtherCommon Stock 5,859 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000477 · edgar.xml · nonDerivative · entry 2

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By John Freund Family Partnership IV, L.P.

Disclosed balance after: 26,365

F3 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to the reporting person.

F4 · ownership.nature: The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The reporting person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The reporting person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein.

Read SEC document
November 14, 2018 Filed Nov 16, 2018 21:16 UTC OtherCommon Stock 400,000 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000477 · edgar.xml · nonDerivative · entry 1

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Skyline Venture Partners V, L.P.

Disclosed balance after: 1,149,916

F1 · kind: Represents a pro rata in-kind distribution of the shares by Skyline Venture Partners V, L.P. without consideration to its limited and general partners.

F2 · ownership.nature: The shares are held by Skyline Venture Partners V, L.P. The general partner of Skyline Venture Partners V, L.P. is Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management, LLC. Dr. Freund disclaims beneficial ownership of all the shares held by Skyline Venture Partners V, L.P. except to the extent of his proportionate pecuniary interest therein.

Read SEC document
October 15, 2018 Filed Oct 17, 2018 20:27 UTC SaleCommon Stock 25,000 $16.53 $413,250.00
Disclosure

SEC source: 0001192482-18-000460 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 361,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2018.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.40 to $16.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2).

Read SEC document
August 23, 2018 Filed Aug 27, 2018 16:04 UTC
Fleming Alison BChief Technology Officer
Tax withholdingCommon Stock 599 $18.03 $10,799.97
Disclosure

SEC source: 0001192482-18-000413 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,582

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
August 23, 2018 Filed Aug 27, 2018 20:06 UTC Tax withholdingCommon Stock 2,025 $18.03 $36,510.75
Disclosure

SEC source: 0001192482-18-000414 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 386,000

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
August 23, 2018 Filed Aug 27, 2018 20:07 UTC
Brannelly PaulExecutive Vice President & CFO
Tax withholdingCommon Stock 599 $18.03 $10,799.97
Disclosure

SEC source: 0001192482-18-000415 · edgar.xml · nonDerivative · entry 1

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,195

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
August 03, 2018 Filed Aug 6, 2018 17:39 UTC
Fleming Alison BChief Technology Officer
Tax withholdingCommon Stock 181 $20.15 $3,647.15
Disclosure

SEC source: 0001192482-18-000376 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,181

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
August 03, 2018 Filed Aug 6, 2018 21:41 UTC Tax withholdingCommon Stock 668 $20.15 $13,460.20
Disclosure

SEC source: 0001192482-18-000378 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 388,025

F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
August 03, 2018 Filed Aug 6, 2018 21:43 UTC
Brannelly PaulExecutive Vice President & CFO
Tax withholdingCommon Stock 181 $20.15 $3,647.15
Disclosure

SEC source: 0001192482-18-000380 · edgar.xml · nonDerivative · entry 2

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,794

F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
July 27, 2018 Filed Aug 6, 2018 21:43 UTC
Brannelly PaulExecutive Vice President & CFO
GrantCommon Stock 539 $15.84 $8,537.76
Disclosure

SEC source: 0001192482-18-000380 · edgar.xml · nonDerivative · entry 1

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,975

F1 · kind: These shares were acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
July 10, 2018 Filed Jul 12, 2018 20:41 UTC
Dreyer ScottEVP & Chief Commercial Officer
GrantCommon Stock 16,186 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000337 · edgar.xml · nonDerivative · entry 1

Dreyer Scott · CIK 0001746251 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,186

F1 · security: Reflects the grant of restricted stock units in connection with the reporting person's promotion to Chief Commercial Officer of the issuer. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on July 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
July 01, 2018 Filed Jul 2, 2018 21:44 UTC
Ciaffoni JosephDirector · President and CEO
GrantStock Option (Right to Purchase) · Derivative 41,418 $0.00 Strike: $23.85 $0.00
Disclosure

SEC source: 0001192482-18-000329 · edgar.xml · derivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,418

Underlying: Common Stock · 41,418 shares

Expires 2028-07-01

F2 · derivative.exercise_date: Twenty-five percent (25%) of the option vests and becomes exercisable on July 1, 2019, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer.

Read SEC document
July 01, 2018 Filed Jul 2, 2018 21:44 UTC
Ciaffoni JosephDirector · President and CEO
GrantCommon Stock 25,140 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000329 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,341

F1 · shares: Reflects the grant of restricted stock units in connection with the reporting person's promotion to Chief Executive Officer of the issuer. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on July 1, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.

Read SEC document
June 21, 2018 Filed Jun 22, 2018 22:25 UTC
Brannelly PaulExecutive Vice President & CFO
SaleCommon Stock 4,900 $28.35 $138,915.00
Disclosure

SEC source: 0001192482-18-000320 · edgar.xml · nonDerivative · entry 2

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,436

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2018.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.84 to $28.55, inclusive.

Read SEC document
June 21, 2018 Filed Jun 22, 2018 22:25 UTC
Brannelly PaulExecutive Vice President & CFO
SaleCommon Stock 5,100 $27.50 $140,250.00
Disclosure

SEC source: 0001192482-18-000320 · edgar.xml · nonDerivative · entry 1

Brannelly Paul · CIK 0001394936 · Executive Vice President & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,336

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2018.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.80 to $27.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.

Read SEC document
June 12, 2018 Filed Jun 13, 2018 16:58 UTC
Fleming Alison BChief Technology Officer
SaleCommon Stock 4,096 $27.00 $110,592.00
Disclosure

SEC source: 0001192482-18-000292 · edgar.xml · nonDerivative · entry 1

Fleming Alison B · CIK 0001640701 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,362

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.

Read SEC document
June 12, 2018 Filed Jun 13, 2018 20:56 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
SaleCommon Stock 53,057 $25.26 $1,340,219.82
Disclosure

SEC source: 0001192482-18-000290 · edgar.xml · nonDerivative · entry 2

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 388,693

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.52, inclusive.

Read SEC document
June 11, 2018 Filed Jun 13, 2018 20:56 UTC
Heffernan Michael ThomasDirector · Chairman, President and CEO
SaleCommon Stock 96,943 $25.28 $2,450,719.04
Disclosure

SEC source: 0001192482-18-000290 · edgar.xml · nonDerivative · entry 1

Heffernan Michael Thomas · CIK 0001448914 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 441,750

F1 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2).

Read SEC document
June 01, 2018 Filed Jun 4, 2018 22:00 UTC
Ciaffoni JosephChief Operating Officer
SaleCommon Stock 14,862 $22.48 $334,097.76
Disclosure

SEC source: 0001192482-18-000260 · edgar.xml · nonDerivative · entry 5

Ciaffoni Joseph · CIK 0001443841 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,201

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2017.

F5 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.14 to $22.91, inclusive.

Read SEC document
May 31, 2018 Filed Jun 4, 2018 22:00 UTC
Ciaffoni JosephChief Operating Officer
Exercise / conversionStock option (right to purchase) · Derivative 64,821 $0.00 Strike: $8.22 $0.00
Disclosure

SEC source: 0001192482-18-000260 · edgar.xml · derivative · entry 6

Ciaffoni Joseph · CIK 0001443841 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,462

Underlying: Common Stock · 64,821 shares

Expires 2027-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: 64,821 shares subject to the option vested and became exercisable on May 31, 2018. The remaining 194,462 shares subject to the option vest in equal quarterly installments (rounded up to the nearest whole share of common stock) over a three year period, subject to the reporting person's continued service with the issuer.

Read SEC document
May 31, 2018 Filed Jun 4, 2018 22:00 UTC
Ciaffoni JosephChief Operating Officer
Tax withholdingCommon Stock 6,205 $22.62 $140,357.10
Disclosure

SEC source: 0001192482-18-000260 · edgar.xml · nonDerivative · entry 4

Ciaffoni Joseph · CIK 0001443841 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,063

F4 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.

Read SEC document
May 31, 2018 Filed Jun 4, 2018 22:00 UTC
Ciaffoni JosephChief Operating Officer
SaleCommon Stock 5,617 $23.35 $131,156.95
Disclosure

SEC source: 0001192482-18-000260 · edgar.xml · nonDerivative · entry 3

Ciaffoni Joseph · CIK 0001443841 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,268

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2017.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.10 to $23.45, inclusive.

Read SEC document
May 31, 2018 Filed Jun 4, 2018 22:00 UTC
Ciaffoni JosephChief Operating Officer
SaleCommon Stock 59,204 $22.54 $1,334,458.16
Disclosure

SEC source: 0001192482-18-000260 · edgar.xml · nonDerivative · entry 2

Ciaffoni Joseph · CIK 0001443841 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,885

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2017.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.10 to $23.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (5).

Read SEC document
May 31, 2018 Filed Jun 4, 2018 22:00 UTC
Ciaffoni JosephChief Operating Officer
Exercise / conversionCommon Stock 64,821 $8.22 $532,828.62
Disclosure

SEC source: 0001192482-18-000260 · edgar.xml · nonDerivative · entry 1

Ciaffoni Joseph · CIK 0001443841 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,089

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:07 UTC GrantStock Option (Right to Purchase) · Derivative 4,506 $0.00 Strike: $24.95 $0.00
Disclosure

SEC source: 0001192482-18-000255 · edgar.xml · derivative · entry 2

Schroeder Theodore R · CIK 0001378690 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,506

Underlying: Common Stock · 4,506 shares

Expires 2028-05-24

F2 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:07 UTC GrantCommon Stock 2,253 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000255 · edgar.xml · nonDerivative · entry 1

Schroeder Theodore R · CIK 0001378690 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,253

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:04 UTC GrantStock Option (Right to Purchase) · Derivative 4,506 $0.00 Strike: $24.95 $0.00
Disclosure

SEC source: 0001192482-18-000252 · edgar.xml · derivative · entry 4

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,506

Underlying: Common Stock · 4,506 shares

Expires 2028-05-24

F4 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:04 UTC GrantCommon Stock 2,253 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000252 · edgar.xml · nonDerivative · entry 1

Freund John Gordon · CIK 0001296771 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,253

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:01 UTC
SANTINI GINODirector
GrantStock Option (Right to Purchase) · Derivative 4,506 $0.00 Strike: $24.95 $0.00
Disclosure

SEC source: 0001192482-18-000250 · edgar.xml · derivative · entry 2

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,506

Underlying: Common Stock · 4,506 shares

Expires 2028-05-24

F2 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:01 UTC
SANTINI GINODirector
GrantCommon Stock 2,253 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000250 · edgar.xml · nonDerivative · entry 1

SANTINI GINO · CIK 0001276038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,441

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:08 UTC GrantStock Option (Right to Purchase) · Derivative 4,506 $0.00 Strike: $24.95 $0.00
Disclosure

SEC source: 0001192482-18-000256 · edgar.xml · derivative · entry 2

Fallon John A. · CIK 0001560152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,506

Underlying: Common Stock · 4,506 shares

Expires 2028-05-24

F2 · derivative.exercise_date: The option vests and becomes exercisable on May 24, 2019, subject to the director's continued service with the issuer.

Read SEC document
May 24, 2018 Filed May 29, 2018 21:08 UTC GrantCommon Stock 2,253 $0.00 $0.00
Disclosure

SEC source: 0001192482-18-000256 · edgar.xml · nonDerivative · entry 1

Fallon John A. · CIK 0001560152 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,628

F1 · shares: Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest on May 24, 2019, subject to the director's continued service with the issuer. The restricted stock units will be settled on such date in shares of the issuer's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.